SCM
ARCT icon

Shelton Capital Management’s Arcturus Therapeutics ARCT Stock Holding History

Shelton Capital Management’s Portfolio ARCT Stock Details ARCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-45,300
Closed -$671K – 681
2022
Q3 		$671K Sell
45,300
-7,700
-15% -$129K 0.03% 273
2022
Q2 		$834K Hold
53,000
– – 0.04% 270
2022
Q1 		$1.43M Buy
53,000
+5,000
+10% +$128K 0.05% 245
2021
Q4 		$1.78M Hold
48,000
– – 0.06% 241
2021
Q3 		$2.29M Buy
48,000
+10,000
+26% +$448K 0.09% 215
2021
Q2 		$1.29M Buy
38,000
+7,800
+26% +$264K 0.05% 259
2021
Q1 		$1.25M Buy
+30,200
New +$1.8M 0.04% 275

Other funds holding ARCT

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $50.9B AUM 42.89% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return